The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Does therapy-related myelofibrosis exist? Analysis of 1100 myelofibrosis cases from a single institution.
 
Lucia Masarova
No Relationships to Disclose
 
Prithviraj Bose
No Relationships to Disclose
 
Naveen Pemmaraju
Honoraria - Incyte; LFB Biotechnologies; Novartis
Consulting or Advisory Role - Incyte; LFB Biotechnologies; Novartis
Research Funding - Incyte; Novartis; Stemline Therapeutics
 
Naval Guastad Daver
No Relationships to Disclose
 
Kate Newberry
No Relationships to Disclose
 
Jorge E. Cortes
Consulting or Advisory Role - Ambit BioSciences; Amphivena Therapeutics; ARIAD; Astellas Pharma; BiolineRx; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Teva (Inst)
 
Hagop M. Kantarjian
Research Funding - Amgen (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Delta-Fly Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Srdan Verstovsek
No Relationships to Disclose